Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to include new information about various types of neuroendocrine carcinomas and their treatment, as well as the addition of collaborators and a revision number. Notably, the previous detailed description of a phase II trial involving nivolumab and temozolomide has been removed.SummaryDifference54%
- Check30 days agoChange DetectedThe page has updated the treatment information for Nivolumab and Temozolomide, reflecting new dates for clinical relevance and a revision update from v2.14.3 to v2.14.4.SummaryDifference0.9%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.